| abstract |
The invention relates to the use of a compound according to the invention in combination with one or more additional agents for treating cough, allergy or asthma symptoms, selected from the group consisting of: antihistamines, 5-lipoxygenase inhibitors, leukotriene inhibitors , histamine H3 receptor inhibitors, beta-adrenergic receptor agonists, xanthine derivatives, alpha-adrenergic receptor agonists, mast cell stabilizers, cough suppressants, expectorants, tachykinin receptor antagonists NK1, NK2 and NK3 and agonists of GABAB for the manufacture of a medicine to treat cough, pain, anxiety, asthma, alcohol abuse or depression. |